These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16012196)

  • 1. Functions of heteromeric association between adenosine and P2Y receptors.
    Nakata H; Yoshioka K; Kamiya T; Tsuga H; Oyanagi K
    J Mol Neurosci; 2005; 26(2-3):233-8. PubMed ID: 16012196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromeric association creates a P2Y-like adenosine receptor.
    Yoshioka K; Saitoh O; Nakata H
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7617-22. PubMed ID: 11390975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains.
    Yoshioka K; Hosoda R; Kuroda Y; Nakata H
    FEBS Lett; 2002 Nov; 531(2):299-303. PubMed ID: 12417330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor.
    Suzuki T; Namba K; Tsuga H; Nakata H
    Biochem Biophys Res Commun; 2006 Dec; 351(2):559-65. PubMed ID: 17070771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
    Yoshioka K; Nakata H
    J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.
    Yoshioka K; Saitoh O; Nakata H
    FEBS Lett; 2002 Jul; 523(1-3):147-51. PubMed ID: 12123822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hetero-oligomerization and Functional Interaction between Purinergic Receptors Expressed in Platelets to Regulate Platelet Shape Change].
    Suzuki T
    Yakugaku Zasshi; 2015; 135(12):1335-40. PubMed ID: 26632148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
    Ecke D; Hanck T; Tulapurkar ME; Schäfer R; Kassack M; Stricker R; Reiser G
    Biochem J; 2008 Jan; 409(1):107-16. PubMed ID: 17824841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic-receptor oligomerization: implications for neural functions in the central nervous system.
    Nakata H; Yoshioka K; Kamiya T
    Neurotox Res; 2004; 6(4):291-7. PubMed ID: 15545012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogold electron microscopic evidence of in situ formation of homo- and heteromeric purinergic adenosine A1 and P2Y2 receptors in rat brain.
    Namba K; Suzuki T; Nakata H
    BMC Res Notes; 2010 Nov; 3():323. PubMed ID: 21114816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
    Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
    Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
    Horiuchi T; Dietrich HH; Hongo K; Dacey RG
    Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL; Romero-Avila T; Schachter JB; Harden TK
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and molecular evidence for heteromeric association of P2Y1 receptor with P2Y2 and P2Y4 receptors in mouse granulocytes.
    Ribeiro-Filho AC; Buri MV; Barros CC; Dreyfuss JL; Nader HB; Justo GZ; Craveiro RB; Pesquero JB; Miranda A; Ferreira AT; Paredes-Gamero EJ
    BMC Pharmacol Toxicol; 2016 Jul; 17(1):29. PubMed ID: 27384918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
    Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
    BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human adenosine A1 receptor and P2Y2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells.
    Dickenson JM; Blank JL; Hill SJ
    Br J Pharmacol; 1998 Aug; 124(7):1491-9. PubMed ID: 9723963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells.
    Tonazzini I; Trincavelli ML; Montali M; Martini C
    J Neurosci Res; 2008 Oct; 86(13):2857-66. PubMed ID: 18500760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL; Lazarowski ER; Chen XH; Harden TK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.